Tumor Dosimetry And Radiobiological Study For High-Activity 131I-mIBG Therapy In The Management Of Refractory/Relapsed Neuroblastoma

被引：0
|
作者：
Polito, C. [1 ]
Cassano, B. [1 ]
Genovese, E. [1 ]
Longo, M. [2 ]
Donatiello, S. [1 ]
Insero, T. [1 ]
Valeri, S. [1 ]
Villani, M. F. [1 ]
Castellano, A. [1 ]
Garganese, M. C. [1 ]
Cannata, V. [1 ]
机构：
[1] IRCCS Bambino Gesu Childrens Hosp, Rome, Italy
[2] Arcispedale St Anna Hosp, Ferrara, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0221
引用
下载
收藏
页码：S484 / S484
页数：1
相关论文
共 50 条
  • [1] Individualised 131I-mIBG Therapy in the Management of Refractory and Relapsed Neuroblastoma
    George, S. L.
    Kirk, S. J.
    Lancaster, D.
    Vaidya, S. J.
    Mandeville, H.
    Saran, F.
    Chittenden, S. J.
    Pearson, A. D. J.
    Du, Y.
    Flux, G. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S244 - S244
  • [2] Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
    George, Sally L.
    Falzone, Nadia
    Chittenden, Sarah
    Kirk, Stephanie J.
    Lancaster, Donna
    Vaidya, Sucheta J.
    Mandeville, Henry
    Saran, Frank
    Pearson, Andrew D. J.
    Du, Yong
    Meller, Simon T.
    Denis-Bacelar, Ana M.
    Flux, Glenn D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (05) : 466 - 472
  • [3] 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma: An individualised approach
    George, S.
    Kirk, S. J.
    Lancaster, D.
    Vaidya, S. J.
    Mandeville, H.
    Saran, F.
    Chittenden, S.
    Pearson, A. D. J.
    Du, Y.
    Flux, G. D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S352 - S352
  • [4] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Jose Genolla
    Trinidad Rodriguez
    Pablo Minguez
    Ricardo Lopez-Almaraz
    Veronica Llorens
    Aizpea Echebarria
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1567 - 1575
  • [5] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Genolla, Jose
    Rodriguez, Trinidad
    Minguez, Pablo
    Lopez-Almaraz, Ricardo
    Llorens, Veronica
    Echebarria, Aizpea
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1567 - 1575
  • [6] Personalized dosimetry for a deeper understanding of metastatic response to high activity 131I-mIBG therapy in high risk relapsed refractory neuroblastoma
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Valeri, Silvio
    Polito, Claudia
    Donatiello, Salvatore
    Altini, Claudio
    Villani, Maria Felicia
    Serra, Annalisa
    Castellano, Aurora
    Garganese, Maria Carmen
    Cannata, Vittorio
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (02) : 1299 - 1310
  • [7] Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    Maric, Ines
    Weber, Manuel
    Prochnow, Andre
    Schmitz, Jochen
    Unger, Nicole
    Schaarschmidt, Benedikt M.
    Poeppel, Thorsten D.
    Rischpler, Christoph
    Bockisch, Andreas
    Herrmann, Ken
    Jentzen, Walter
    Fendler, Wolfgang P.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 885 - 891
  • [8] Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma
    Anongpornjossakul, Yoch
    Sriwatcharin, Wattanun
    Thamnirat, Kanungnij
    Chamroonrat, Wichana
    Kositwattanarerk, Arpakorn
    Utamakul, Chirawat
    Sritara, Chanika
    Chokesuwattanasakul, Payap
    Thokanit, Nintita Sripaiboonkij
    Pakakasama, Samart
    Anurathapan, Usanarat
    Pongphitcha, Pongpak
    Chotipanich, Chanisa
    Hongeng, Suradej
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (04) : 336 - 343
  • [9] Evaluation of ctDNA in children with relapsed or refractory neuroblastoma treated with 131I-MIBG
    Shulman, David S.
    Klega, Kelly
    Marachelian, Araz
    Matthay, Katherine K.
    Park, Julie R.
    Granger, M. Meaghan
    DuBois, Steven G.
    Crompton, Brian D.
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 66 - 66
  • [10] Tandem High-Dose 131I-MIBG Therapy For Paediatric Patients With Relapsed-Refractory High Risk Neuroblastoma: A Dosimetry Based Treatment
    Altini, C.
    Villani, M.
    Cassano, B.
    Pizzoferro, M.
    Serra, A.
    Castellano, A.
    Cannata, V.
    Garganese, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S689 - S689
12345